Skip to content

Effect of Curodont™ Repair in Patients with Buccal Carious Lesions: A Mono-centre, Controlled, Split-mouth, Single-blinded, Randomised, Post-marketing Study

Effect of Curodont™ Repair in Patients with Buccal Carious Lesions: A Mono-centre, Controlled, Split-mouth, Single-blinded, Randomised, Post-marketing Study - P11-4-BCL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
DRKS
Registry ID
DRKS00012941
Enrollment
25
Registered
2017-09-01
Start date
2012-10-10
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K02.9

Interventions

Group 1: Single local treatment of initial caries lesion with Curodont Repair on Day 0 and Day 90
Treatment time: ~5 Minutes. Group 2: Single local treatment of initial caries lesions with Fluoride Varnish (Duraphat) on Day 0 and Day 90
Treatment time: 2 Minutes

Sponsors

credentis ag
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 65 Years

Inclusion criteria

Inclusion criteria: • Two buccal carious lesions which do not require operative intervention • Size and form of the lesions: the lesions must both be fully visible and assessable and accessible • Patients must be able and willing to observe good oral hygiene throughout the study • = 20 teeth and a plaque index of < 20% • Age = 10 years and = 65 years • Willing and able to attend the on-study visits • Willing and able to understand all study-related procedures • Written informed consent before participation in the study

Exclusion criteria

Exclusion criteria: • Secondary caries lesion on tooth • Enamel aberration • Carious lesions due to orthodontic treatment on tooth • Evidence of tooth erosion (due to excessive acidic drink consumption or reflux) • History of head and neck illnesses (e.g. head/neck cancer) • Any pathology or concomitant medication affecting salivary flow or dry mouth • Any metabolic disorders affecting bone turnover • Concurrent participation in another clinical trial with an investigational drug or device or participation in another clinical trial with an investigational drug or device within 30 days prior to study entry

Design outcomes

Primary

MeasureTime frame
Difference of the change in the lesion's size assessed by morphometry (on standardised photographs) from baseline D0 to D30 between investigational medical device and fluoride varnish.

Secondary

MeasureTime frame
Difference of the change in the lesion's size assessed by morphometry (on standardised photographs) from baseline D0 to D90, D180, D360 between investigational medical device and fluoride varnish.

Countries

Germany

Contacts

Public ContactFrank Bröseler

Zahnärztliche Praxis für Parodontologie

rezeption@paro-aachen.de0241 918450

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 3, 2026